The evolving role of artificial intelligence in optimizing treatment and patient selection in diabetic macular edema
{{output}}
Anti-vascular endothelial growth factor (anti-VEGF) therapy is the mainstay of management for diabetic macular edema (DME), but marked variability in response, high injection frequency, and cumulative treatment burden highlight the need for tools that can indi... ...
